Sufferers say the pain caused by the nerve disorder is so debilitating that they can’t smile, laugh or even make eye contact with another person.

Noninvasive therapy seeks to enhance focus and behavior by gently stimulating a nerve associated with attention and executive ...

Discover why headaches strike one side of your head, from migraines to nerve disorders, and learn the warning signs that ...

Atypical trigeminal neuralgia (ATN) is a chronic pain condition characterized by persistent facial pain that does not respond ...

The following is a summary of “Suicidal Ideation and Self-Injury in Trigeminal Neuralgia,” published in the April 2025 issue ...

Atypical trigeminal neuralgia (ATN) is a chronic pain condition characterized by persistent facial pain that does not respond ...

Trial to be conducted at UCLA and funded by a grant from National Institute on Alcohol Abuse and Alcoholism (NIAAA)First ...

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) filed its 510(k) submission to the FDA for trigeminal nerve ablation ...

Atypical trigeminal neuralgia (ATN) is a chronic pain condition characterized by persistent facial pain that does not respond well to conventional medical treatments, often leading to significant ...

NeuroOne (Nasdaq:NMTC) announced today that it filed an FDA 510(k) submission for its trigeminal nerve ablation technology.

NeuroOne filed its FDA 510(k) for trigeminal nerve ablation months ahead of its revised May 2025 timeline. OneRF system targets trigeminal neuralgia, a condition impacting ~100K in the U.S., using ...